Defunct Company
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
106
NCT02713841
Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 31, 2013
Completion: Jul 31, 2013
NCT02716610
Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes
Start: Oct 31, 2013
Completion: Jan 31, 2014
NCT03307512
PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD
Phase: Phase 2
Start: Feb 6, 2018
Completion: Aug 30, 2019
NCT04100473
Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus
Start: Apr 23, 2018
Completion: Aug 1, 2019
NCT03867006
Optimization of the Preservation of Muscle Mass and / or Its Recovery by a Protein-energy Chrononutrition Approach Dissociated From Meals
Phase: N/A
Role: Collaborator
Start: Feb 8, 2019
Completion: Oct 31, 2022